Literature DB >> 21779002

Tumorigenesis: oncogene detox programme.

Nicola McCarthy.   

Abstract

Year:  2011        PMID： 21779002     DOI： 10.1038/nrc3119

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  6 in total

Review 1.  NRF2 and cancer: the good, the bad and the importance of context.

Authors:  Michael B Sporn; Karen T Liby
Journal:  Nat Rev Cancer       Date:  2012-07-19       Impact factor: 60.716

Review 2.  Emerging frontiers in pancreatic cancer research: elaboration of key genes, cells and the extracellular milieu.

Authors:  Chandan Kumar-Sinha; Iris Wei; Diane M Simeone
Journal:  Curr Opin Gastroenterol       Date:  2012-09       Impact factor: 3.287

3.  The Relevance of Nrf2 Pathway and Autophagy in Pancreatic Cancer Cells upon Stimulation of Reactive Oxygen Species.

Authors:  Lun Zhang; Jiahui Li; Jiguang Ma; Xin Chen; Ke Chen; Zhengdong Jiang; Liang Zong; Shuo Yu; Xuqi Li; Qinhong Xu; Jianjun Lei; Wanxing Duan; Wei Li; Tao Shan; Qingyong Ma; Xin Shen
Journal:  Oxid Med Cell Longev       Date:  2015-11-22       Impact factor: 6.543

4.  Loss-of-function mutations in KEAP1 drive lung cancer progression via KEAP1/NRF2 pathway activation.

Authors:  Meiling Gong; Yan Li; Xiaoping Ye; Linlin Zhang; Zhifang Wang; Xiaowen Xu; Yejing Shen; Cuixia Zheng
Journal:  Cell Commun Signal       Date:  2020-06-23       Impact factor: 5.712

Review 5.  The involvement of NRF2 in lung cancer.

Authors:  Alison K Bauer; Thomas Hill; Carla-Maria Alexander
Journal:  Oxid Med Cell Longev       Date:  2013-03-18       Impact factor: 6.543

Review 6.  Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer.

Authors:  Lun Zhang; Jiahui Li; Liang Zong; Xin Chen; Ke Chen; Zhengdong Jiang; Ligang Nan; Xuqi Li; Wei Li; Tao Shan; Qingyong Ma; Zhenhua Ma
Journal:  Oxid Med Cell Longev       Date:  2016-01-03       Impact factor: 6.543
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.